Table 4.
Prevalence of respiratory symptoms according to HIV status and PFT results
HIV-infected | HIV-uninfected | |||||
---|---|---|---|---|---|---|
| ||||||
Respiratory symptom | DLCO≤60% | DLCO>60% | p-value | DLCO≤60% | DLCO>60% | p-value |
| ||||||
Usual cough | 43% | 21% | <0.001 | 26% | 18% | 0.2 |
Usual phlegm | 42% | 28% | 0.02 | 29% | 22% | 0.3 |
Wheeze | 26% | 25% | 0.8 | 29% | 23% | 0.3 |
MRC dyspnea≥2 | 29% | 9% | <0.001 | 16% | 9% | 0.17 |
| ||||||
FEV1/FVC<0.70 | FEV1/FVC≥0.70 | p-value | FEV1/FVC<0.70 | FEV1/FVC≥0.70 | p-value | |
| ||||||
Usual cough | 53% | 22% | <0.001 | 21% | 19% | 0.8 |
Usual phlegm | 59% | 27% | <0.001 | 20% | 25% | 0.5 |
Wheeze | 43% | 22% | 0.001 | 33% | 22% | 0.1 |
MRC dyspnea≥2 | 31% | 11% | <0.001 | 11% | 10% | 0.7 |
p-values represent comparisons by PFT strata within HIV-infected or within HIV-uninfected participants.
DLCO results are presented as above or below 60% of predicted normal.